Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle

被引:151
作者
Möller, B [1 ]
Rasmussen, C [1 ]
Lindblom, B [1 ]
Olovsson, M [1 ]
机构
[1] Uppsala Univ, Sect Obstet & Gynaecol, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden
关键词
angiogenesis; EGF; endometrium; FGF-2; VEGF;
D O I
10.1093/molehr/7.1.65
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Angiogenesis is an important but poorly understood process of the cycling endometrium, Endometrial angiogenesis is believed to be regulated by angiogenic growth factors under the influence of ovarian steroids. Vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2, fibroblast growth factor 2 (FGF-2) and its receptors FGFR-1 and FGFR-2, as well as epidermal growth factor (EGP) and its receptor EGFR are believed to be important in the control of angiogenesis in the human endometrium, Their expression was examined by immunohistochemistry in endometrial biopsies obtained from 16 healthy women with proven fertility. Western blot analysis showed that the primary antibodies used were specific for their epitopes. We found that VEGF, FGF-2, EGF and their receptors were all expressed, especially in and/or around blood vessels, thus supporting the hypothesis that these peptides contribute to the regulation of angiogenesis and blood vessel function in the human endometrium, The receptors VEGFR-1, VEGFR-2, FGFR-2 and EGFR were co-expressed and exhibited their strongest expression during the beginning of the secretory phase, coinciding with the developing endometrial oedema and formation of a complex subepithelial capillary plexus. No correlation was seen between receptor expression and stromal blood vessel density.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 67 条
[61]  
Torry DS, 1997, AM J REPROD IMMUNOL, V37, P21
[62]   Vascular endothelial growth factor expression in cycling human endometrium [J].
Torry, DS ;
Holt, VJ ;
Keenan, JA ;
Harris, G ;
Caudle, MR ;
Torry, RJ .
FERTILITY AND STERILITY, 1996, 66 (01) :72-80
[63]   No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program [J].
Unkila-Kallio, L ;
Vuorela-Vepsäläinen, P ;
Tiitinen, A ;
Halmesmäki, E ;
Ylikorkala, O .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 43 (01) :25-30
[64]   Heparin-binding epidermal growth factor-like growth factor: P91 activation, induction of plasminogen activator plasminogen activator inhibitor, and tubular morphogenesis in human microvascular endothelial cells [J].
Ushiro, S ;
Ono, M ;
Izumi, H ;
Kohno, K ;
Taniguchi, N ;
Higashiyama, S ;
Kuwano, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (01) :68-77
[65]  
VESSEY MP, 1987, NEW ENGL J MED, V317, P769
[66]   Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant [J].
Whittle, C ;
Gillespie, K ;
Harrison, R ;
Mathieson, PW ;
Harper, SJ .
CLINICAL SCIENCE, 1999, 97 (03) :303-312
[67]   Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus [J].
Winther, H ;
Ahmed, A ;
Dantzer, V .
PLACENTA, 1999, 20 (01) :35-43